Literature DB >> 30060067

A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia.

Sharon Tsay1,2, Sabrina R Williams1, Kaitlin Benedict1, Zintars Beldavs3,4, Monica Farley5,6, Lee Harrison7,8, William Schaffner9,10, Ghinwa Dumyati11,12, Anna Blackstock1, Alice Guh13, Snigdha Vallabhaneni1.   

Abstract

Candidemia and Clostridium difficile infection (CDI) are important healthcare-associated infections that share certain risk factors. We sought to describe candidemia-CDI coinfection using population-based surveillance data. We found that nearly 1 in 10 patients with candidemia had CDI coinfection.

Entities:  

Mesh：

Year:  2019        PMID： 30060067      PMCID： PMC6526712          DOI： 10.1093/cid/ciy607

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  15 in total

1.  Revisiting the source of candidemia: skin or gut?

Authors:  M Nucci; E Anaissie
Journal:  Clin Infect Dis       Date:  2001-11-08       Impact factor: 9.079

2.  Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.

Authors:  Marco Falcone; Alessandro Russo; Federica Iraci; Paolo Carfagna; Paola Goldoni; Vincenzo Vullo; Mario Venditti
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 3.  Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses.

Authors:  M S Seelig
Journal:  Bacteriol Rev       Date:  1966-06

4.  Fungal flora of the normal human small and large intestine.

Authors:  R Cohen; F J Roth; E Delgado; D G Ahearn; M H Kalser
Journal:  N Engl J Med       Date:  1969-03-20       Impact factor: 91.245

5.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

Authors:  Angela Ahlquist Cleveland; Monica M Farley; Lee H Harrison; Betsy Stein; Rosemary Hollick; Shawn R Lockhart; Shelley S Magill; Gordana Derado; Benjamin J Park; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2012-08-14       Impact factor: 9.079

6.  Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.

Authors:  A Russo; M Falcone; M Fantoni; R Murri; L Masucci; P Carfagna; M C Ghezzi; B Posteraro; M Sanguinetti; M Venditti
Journal:  Clin Microbiol Infect       Date:  2015-01-14       Impact factor: 8.067

Review 7.  Management of candidemia in patients with Clostridium difficile infection.

Authors:  Marco Falcone; Mario Venditti; Maurizio Sanguinetti; Brunella Posteraro
Journal:  Expert Rev Anti Infect Ther       Date:  2016-07       Impact factor: 5.091

8.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

9.  Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013.

Authors:  S Vallabhaneni; O Almendares; M M Farley; J Reno; Z T Smith; B Stein; S S Magill; R M Smith; A A Cleveland; F C Lessa
Journal:  Epidemiol Infect       Date:  2015-11-26       Impact factor: 4.434

10.  Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.

Authors:  Michelle M Nerandzic; Kathleen Mullane; Mark A Miller; Farah Babakhani; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079
View more
  1 in total

1.  Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection.

Authors:  Alessandra Oliva; Lucia Aversano; Massimiliano De Angelis; Maria Teresa Mascellino; Maria Claudia Miele; Sergio Morelli; Riccardo Battaglia; Jessica Iera; Giovanni Bruno; Enrico Stefano Corazziari; Maria Rosa Ciardi; Mario Venditti; Claudio Maria Mastroianni; Vincenzo Vullo
Journal:  Open Forum Infect Dis       Date:  2019-12-03       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.